All Type of News
Lee to tap new KFDA chief next year
President Lee Myung-bak is expected to delay the appointment of a new Korea Food and Drug Administration commissioner early next year due to the sudden death of North Korean leader Kim Jong-il, according to Chong Wa D...
Local bio drug industry has been overestimated
The domestic market for the biosimilar industry is projected to grow to 14 trillion won by 2015, especially after 2013 when patents for major innovator pharmaceuticals expire, according to the Korea Food and Drug Admi...
Government to boost pay-for-performance compensation scheme
The Health Insurance Review and Assessment Service (HIRA) plans to expand the pay-for-performance compensation system, which has been effective in health insurance, rewarding different medical entities for reaching ta...
Daewoong forges strategic tie-ups with 10 multinational firms
Daewoong Pharmaceutical Co. has established its marketing and distribution partnerships with 10 foreign drug companies, including Boehringer Ingelheim and Pfizer, in an effort to lower costs and enhance competitivenes...
Biosimilar vitalizing Korea’s drug industry
Biosimilars are widely seen as a new engine of Korea’s economic growth. The drug company that pioneered its production now boasts of the largest market cap not only among pharmaceutical firms but also among the KOSDAQ...
Sluggish sales take toll on small drugmakers
A deadly cocktail of poor performance and planned drug price cuts have sent domestic drug firms’ confidence into a tailspin, fanning worries over target sales.
“Overall sentiment of small- and medium-sized pharmace...
Government urged to introduce new prescription plan
Pharmacists yesterday called on the government to push a new prescription plan, under which doctors will be required to prescribe the active pharmaceutical ingredients instead of the name of a specific drug product as...
Yungjin files 'KT&G101’ application for marketing approval with KFDA
Biopid Co., a local biopharmaceutical company, said yesterday that its partner, Yungjin Pharma, has filed a marketing application for a new drug 'KT&G101’ for treatment of atopic dermatitis with the Korea Food and Dru...
More domestic firms seeking co-marketing with multinational firms
With possible means and methods, a growing number of Korean drug firms are rushing to establish strategic alliances with multinational firms here for co-marketing of new drugs, with a fierce war prompted by many compa...
‘Big 4’ drugmakers gain 30% of revenue from other products
Details of leading domestic pharmaceutical firms’ revenue between January and September this year revealed by Yakup.com show that the country's top four pharmaceutical companies on average earned about 30 percent of t...
